Presentation today updates the Ovarian trial timelines. Clearly more work to do there and results delayed to early 2017 (from 2016).
The presentation out today is interesting but the hidden message is that some of the timelines are a bit delayed. Breast cancer / PTX-200 looks the same as before though.
- Forums
- ASX - By Stock
- PTX
- Ann: RedChip Issues Research on Prescient Therapeutics
Ann: RedChip Issues Research on Prescient Therapeutics, page-7
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
3.9¢ | 4.2¢ | 3.8¢ | $64.33K | 1.650M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 35499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.039 |
3 | 172200 | 0.038 |
7 | 529360 | 0.037 |
8 | 688946 | 0.036 |
7 | 571733 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 35499 | 1 |
0.042 | 200000 | 1 |
0.045 | 409634 | 4 |
0.046 | 200000 | 1 |
0.047 | 588389 | 2 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online